Literature DB >> 26622682

Clinical implications of PTEN and VEGF expression status, as well as microvessel density in esophageal squamous cell carcinoma.

Wei Qu1, Jin-Dong Fu2, Fang Yang3, Gong-Li Yang4, Ya-Li Zhang4, Xin-Ying Wang4, Hong-Xiang Gu4, Hai-Yan Zhang3, Ling Wang3.   

Abstract

There are limitations to the use of single biomarker levels, for example phosphate and tensin homology (PTEN) or vascular endothelial growth factor (VEGF), in the diagnosis of esophageal squamous cell carcinoma (ESCC). The present study therefore aimed to evaluate the clinical implications of combined detection of multiple biomarkers. The associations between PTEN and VEGF expression status, microvessel density (MVD), and the pathological characteristics of 50 patients with ESCC were determined using χ2, analysis of variance, and t-tests. The results indicated that the PTEN-positive rate was negatively correlated with ESCC histological grade (P<0.01), depth of ESCC invasion (P<0.01) and lymph node metastasis status. Furthermore, the VEGF-positive rate was correlated with lymph node metastasis status, while MVD was correlated with the depth of ESCC invasion (P<0.01) and lymph node metastasis status (P<0.05). The PTEN-positive rate was negatively correlated with the VEGF-positive rate. A higher MVD was identified in ESCC samples than that of the normal esophageal mucosa, particularly in VEGF-positive ESCC specimens compared with those of VEGF-negative specimens, and PTEN-negative ESCC specimens compared with that of the PTEN-positive ESCC specimens. These results suggested that combined detection of PTEN and VEGF levels, as well as evaluation of MVD in patients with ESCC may provide essential information for improvements in the diagnosis and prognosis of ESCC.

Entities:  

Keywords:  cluster of differentiation 31; esophageal squamous cell carcinoma; microvessel density; phosphate and tensin homolgy; vascular endothelial growth factor

Year:  2015        PMID: 26622682      PMCID: PMC4533295          DOI: 10.3892/ol.2015.3431

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  29 in total

Review 1.  Tumor interactions with the vasculature: angiogenesis and tumor metastasis.

Authors:  C H Blood; B R Zetter
Journal:  Biochim Biophys Acta       Date:  1990-06-01

Review 2.  PTEN: life as a tumor suppressor.

Authors:  L Simpson; R Parsons
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

3.  Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer.

Authors:  Zeljko Sundov; Snjezana Tomic; Stanko Alfirevic; Ana Sundov; Vesna Capkun; Zeljko Nincevic; Jasna Nincevic; Nenad Kunac; Miso Kontic; Nikola Poljak; Nikica Druzijanic
Journal:  Hepatogastroenterology       Date:  2013-05

4.  Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China.

Authors:  D Chang; T-Y Wang; H-C Li; J-C Wei; J-X Song
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

5.  Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.

Authors:  Tatsuya Tanaka; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Takeyasu Katada; Midori Shiozaki; Yasuhiro Naganawa; Yoshitaka Fujii; Hiromitsu Takeyama
Journal:  J Exp Clin Cancer Res       Date:  2010-06-28

6.  Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.

Authors:  Guillaume Banneau; Mickaël Guedj; Gaëtan MacGrogan; Isabelle de Mascarel; Valerie Velasco; Renaud Schiappa; Valerie Bonadona; Albert David; Catherine Dugast; Brigitte Gilbert-Dussardier; Olivier Ingster; Pierre Vabres; Frederic Caux; Aurelien de Reynies; Richard Iggo; Nicolas Sevenet; Françoise Bonnet; Michel Longy
Journal:  Breast Cancer Res       Date:  2010-08-16       Impact factor: 6.466

7.  Growth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding products.

Authors:  Hua-Chuan Zheng; Yi-Ling Li; Jin-Min Sun; Xue-Fei Yang; Xiao-Han Li; Wei-Guo Jiang; Yin-Chang Zhang; Yan Xin
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

8.  PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma.

Authors:  Q F Pan; W T Li; H C Dong; Y Z Chen; L Yin; W Liu; W W Wang; D Liu; S G Li; W Y Gu; J Z Chen; L Yang; W J Zhang; F Li
Journal:  Dis Esophagus       Date:  2013-08-27       Impact factor: 3.429

9.  Prognostic value of vascular endothelial growth factor expression in patients with esophageal cancer: a systematic review and meta-analysis.

Authors:  Meilan Chen; Erhui Cai; Jizheng Huang; Ping Yu; Ke Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-07       Impact factor: 4.254

10.  Chapter 14. Measuring intratumoral microvessel density.

Authors:  Noel Weidner
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

View more
  2 in total

Review 1.  Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma.

Authors:  Rong Qiu; Wenxi Wang; Juan Li; Yuxiang Wang
Journal:  Mol Biol Rep       Date:  2022-03-17       Impact factor: 2.742

2.  Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma.

Authors:  Jianqiang Li; Lifen Wang
Journal:  Onco Targets Ther       Date:  2017-08-07       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.